RSS-Feed abonnieren
DOI: 10.1055/s-0041-1736724
β2-adrenoceptor deficiency in experimental osteoarthritis leads to exacerbation of subchondral bone changes without affecting cartilage and synovium
Introduction
Recent studies demonstrated a contribution of the sympathetic nervous system and its major neurotransmitter norepinephrine (NE) to osteoarthritis (OA) pathogenesis. The effects of NE are predominantly catabolic in cartilage and subchondral bone, while mainly anti-inflammatory in the synovial tissue [1] [2]. Several adrenoceptor (AR) subtypes are expressed in different joint tissues [3] but the current literature suggests that the β2-AR plays a crucial role during OA pathogenesis [4] [5] [6]. Therefore, we examined the progression of surgically induced OA in β2-AR-deficient (Adrb2-/-) mice.
Publikationsverlauf
Artikel online veröffentlicht:
04. November 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart,
Germany
-
References
- 1 Lorenz et al. Osteoarthritis Cartilage 2016, vol. 24, no. 2, pp. 325–34
- 2 Jiao et al. Scientific Reports 2016, vol. 6, no. 1, p. 30085
- 3 Sohn et al. Cell Signal, vol. 82, p. 109948
- 4 Aitken et al. Arch Biochem Biophys 2009, vol. 482, no. 1–2, pp. 96–103
- 5 Pai et al. J Cell Biochem 2008, vol. 104, no. 2, pp. 545–53
- 6 Miller et al. J Rheumatol 2002, vol. 29, no. 3, pp. 427–35